David Bernard
Nephrology · New York, NYNPI 1518117712
Payments from drug & device makers
$5,998,239in general payments, 2019–2025
Across 397 payments — averaging $15,109 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bavarian Nordic A/s$2M
- Genentech, Inc.$1.3M
- AstraZeneca$694K
- Pfizer$427K
- Merck$416K
- GSK$330K
- plus $881K from 18 others
$232,513in research payments, 2019–2025
Across 34 payments — averaging $6838.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Applied Therapeutics, Inc.$227K
- Eli Lilly$5K
- Gilead$902
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bavarian Nordic A/s | 78 | $1,997,829 |
| Genentech, Inc. | 52 | $1,251,976 |
| AstraZeneca | 25 | $694,371 |
| Pfizer | 35 | $426,519 |
| Merck | 25 | $416,092 |
| GSK | 21 | $330,151 |
| Intercept Pharmaceuticals, Inc. | 33 | $180,585 |
| Applied Therapeutics, Inc. | 10 | $105,764 |
| Astrazeneca UK Limited | 3 | $93,741 |
| Vanda Pharmaceuticals Inc. | 13 | $74,350 |
| Hikma Pharmaceuticals USA | 5 | $64,866 |
| Amgen | 8 | $58,061 |
| Sanofi US Services Inc. | 10 | $49,013 |
| Teva Pharmaceuticals USA, Inc. | 6 | $39,598 |
| AbbVie | 27 | $38,489 |
| Gilead | 4 | $31,700 |
| Johnson & Johnson | 8 | $30,898 |
| Chiesi USA, Inc. | 7 | $27,702 |
| Bayer | 7 | $26,162 |
| Modernatx, Inc. | 15 | $25,830 |
| Cue Health Inc. | 1 | $14,500 |
| Sanofi-aventis U.S. LLC | 1 | $11,428 |
| Sanofi Pasteur Inc. | 2 | $6,700 |
| Lexicon Pharmaceuticals, Inc. | 1 | $1,914 |
How this compares
$5,998,239 in reported general payments places this provider in the 95th percentile of 935 nephrology providers in New York.
Other nephrology in New York
- Joji TokitaNew York$8.4M
- Krzysztof KirylukNew York$6.7M
- Andrew BombackNew York$3.4M
- Pietro CanettaNew York$3.2M
- Gerald AppelNew York$1.5M
- David CharytanNew York$1.3M
- Kirk CampbellNew York$1.1M
- Jai RadhakrishnanNew York$995K
- Girish NadkarniNew York$978K
- David GoldfarbNew York$808K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.